Skip to main content
Caplight Logo









Up Therapeutics

Up Therapeutics

Private
Frederick, MarylandHealthcare & Life Scienceshttps://uptherapeutics.com/

Total Funding Raised

$2.5M

Company Overview

Up Therapeutics is a biotechnology company that develops small molecule Rpn13 inhibitors for the treatment of various cancers, including solid tumors.

Sector

Healthcare & Life Sciences

Verticals

Drug Discovery, Biotechnology

Business Model

B2B

Customer Profile

Services & Consulting, Revenue Share

AI Layer

Non-AI

Keywords

small molecule inhibitoroncology therapeuticsRPN13 inhibitordrug discoverysolid tumor treatmentbiotech startuppreclinical biotechproteasome inhibitordrug licensingcancer drug developmentfirst-in-class drugtherapeutic pipelinebiotech R&Ddrug candidate

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Sign up to view complete historical pricing and secondary transactions.

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Up Therapeutics Comparables

Compare Up Therapeutics with similar companies based on industry and business-model similarity.

Up Therapeutics comparables — related companies by embedding similarity
CompanySimilarityMarket Cap
SHY Therapeutics
82%
QLi5 Therapeutics GmbH
77%
Ubiquigent Limited
63%

Up Therapeutics Funding Rounds

Historical fundraising activity

View Full Funding History

Access detailed round history, amounts raised, valuations, and investors.

Up Therapeutics Investors

Notable investors and investment history

Up Therapeutics investors
InvestorRounds
National Cancer InstituteGrant
National Institutes of Health (NIH)Grant

Up Therapeutics Filings

Explore SEC and related filing metadata, where available.

Up Therapeutics filings preview — column headings only; records require access
TypeDateAmount OfferedAmount SoldFilingPagesDownload

Filing documents are not displayed on this public page. Request access to learn about available coverage.

Request access

Frequently Asked Questions

Common questions about Up Therapeutics's valuation, stock price, and market status.

Is Up Therapeutics a public or private company?

Up Therapeutics is a private company.

What is the current stock price of Up Therapeutics?

Up Therapeutics is a private company with no public stock price. No recent secondary market data is available.

How much is Up Therapeutics worth (valuation)?

Valuation information for Up Therapeutics is not publicly available.

Can I buy Up Therapeutics stock?

Up Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.

When was Up Therapeutics's last funding round?

Funding round information for Up Therapeutics is not publicly available.

Who are the main investors in Up Therapeutics?

Investor information for Up Therapeutics is not publicly disclosed.

Will Up Therapeutics IPO soon?

No public IPO plans have been announced for Up Therapeutics.

How can I track Up Therapeutics secondary market activity?

Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Up Therapeutics's secondary market activity and sign up for updates.

Firmographic Details

HeadquartersFrederick, Maryland
Year Founded2016
Last Funding—

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.

See something wrong or outdated?